Anhedonia as a Crucial Factor of Depression: Assessment, Neurobiological Underpinnings and Treatment

  • Troy K. Chow
  • Sidney Kennedy
  • Sakina J. Rizvi


Anhedonia is a cardinal symptom of major depressive disorder yet has not received significant attention in the research domain. A major contributor to this disproportionality is the limited understanding of anhedonia. Traditionally conceptualized as a “loss of pleasure”, it is clear that anhedonia includes additional facets including interest, motivation and reward learning. With the construct of anhedonia expanded, the development of new assessment tools, including self-report scales and behavioural tasks, has greatly improved our understanding of the underlying neurobiology. Deficits in nucleus accumbens activity have historically been tied to anhedonia due to its attribution as a “pleasure centre” in the brain. However, it is now known that many other brain regions are involved in the processing of reward. Furthermore, many first-line antidepressant options focus primarily on potentiating serotonin levels, despite dopamine playing an essential role in anhedonia. A greater understanding of anhedonia may allow for more personalized treatment strategies and heavily reduce the significant burden associated with depression. This chapter will review the neurobiology, measurement and treatment of this core symptom of MDD.


Anhedonia Reward processing Neurobiology Major depressive disorder Treatment Assessment 


  1. Chapman LJ, Chapman JP, Raulin ML. Scales for physical and social anhedonia. J Abnorm Psychol. 1976;85:374–82.CrossRefGoogle Scholar
  2. Chase HW, Michael A, Bullmore ET, Sahakian BJ, Robbins TW. Paradoxical enhancement of choice reaction time performance in patients with major depression. J Psychopharmacol. 2010;24(4):471-479.CrossRefGoogle Scholar
  3. Clark DC, Fawcett J, Salazar-Grueso E, Fawcett E. Seven-month clinical outcome of anhedonic and normally hedonic depressed inpatients. Am J Psychiatry. 1984;141:1216–20.CrossRefGoogle Scholar
  4. Cohen MX, Axmacher N, Lernartz G, Baup N, Fossati P, Pessiglione M. Neuroelectric signatures of reward learning and decision-making in the human nucleus accumbens. Neuropsychopharmacology. 2009;34:1649–58.CrossRefGoogle Scholar
  5. Cools R, Blackwell A, Clark L, Menzies L, Cox S, Robbin TW. Tryptophan depletion disrupts the motivational guidance of goal-directed behaviour as a function of trait impulsivity. Neuropsychopharmacology. 2005;30:1362–73.CrossRefGoogle Scholar
  6. Dekeyne A, Gobert A, Auclair A, Girardon S, Millan M. Differential modulation of efficiency in a food-rewarded ‘differential reinforcement of low-rate’ 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors. Psychopharmacology. 2002;162:156–67.CrossRefGoogle Scholar
  7. Demyttenaere K, Corruble E, Hale A, Quera-Salva MA, Picarel-Blanchot F, Kasper S. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline. CNS Spectr. 2013;18(3):163–70.CrossRefGoogle Scholar
  8. Der-Avakian A, Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 2012;35:68–77.CrossRefGoogle Scholar
  9. Dombrovski AY, Siegle GJ, Szanto K, Clark L, Reynolds CF, Aizenstein H. The temptation of suicide: striatal gray matter, discounting of delayed rewards, and suicide attempts in late-life depression. Psychol Med. 2012;42:1203–15.CrossRefGoogle Scholar
  10. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007;64(3):327–37.CrossRefGoogle Scholar
  11. Elliott R, Friston KJ, Dolan RJ. Dissociable neural responses in human reward systems. J Neurosci. 2000;20:6159–65.CrossRefGoogle Scholar
  12. Fawcett J, Clark DC, Scheftner WA, Gibbons RD. Assessing anhedonia in psychiatric patients. Arch Gen Psychiatry. 1983;40:79–84.CrossRefGoogle Scholar
  13. Forbes EE, Hariri AR, Martin SL, Silk JS, Moyles DL, Fisher PM, Brown SM, Ryan ND, Birmaher B, Axelson DA, Dahl RE. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry. 2009;166:64–73.CrossRefGoogle Scholar
  14. Gabbay V, Mao X, Klein RG, Ely BA, Babb JS, Panzer AM, Alonso CM, Shungu DC. Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry. 2012;69:139–49.CrossRefGoogle Scholar
  15. Gard DE, Gard MG, Kring AM, John OP. Anticipatory and consummatory components of the experience of pleasure: a scale development study. J Res Pers. 2006;40:1086–102.CrossRefGoogle Scholar
  16. Gard DE, Kring AM, Gard MG, Horan WP, Green MF. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res. 2007;93:253–60.CrossRefGoogle Scholar
  17. Garfield JB, Cotton SM, Lubman DI. Psychometric properties, validity, and reliability of the temporal experience of Pleasure Scale state version in an opioid-dependent sample. Drug Alcohol Depend. 2016;161:238–46.CrossRefGoogle Scholar
  18. Gargoloff PD, Corral R, Herbst L, Marquez M, Martinotti G, Gargoloff PR. Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world study. Hum Psychopharmacol Clin Exp. 2016;31(6):412–8.CrossRefGoogle Scholar
  19. Gooding DC, Pflum MJ. The assessment of interpersonal pleasure: introduction of the Anticipatory and Consummatory Interpersonal Pleasure Scale (ACIPS) and preliminary findings. Psychiatry Res. 2014;215:237–43.CrossRefGoogle Scholar
  20. Grabenhorst F, Rolls ET. Value, pleasure and choice in the ventral prefrontal cortex. Trends Cogn Sci. 2011;15:56–67.CrossRefGoogle Scholar
  21. Green L, Myerson J, McFadden E. Rate of temporal discounting decreases with amount of reward. Mem Cogn. 1997;25:715–23.CrossRefGoogle Scholar
  22. Hamilton JP, Furman DJ, Chang C, et al. Default-mode and task-positive network activity in major depressive disorder: implications for adaptive and maladaptive rumination. Biol Psychiatry. 2011;70:327–33.CrossRefGoogle Scholar
  23. Hasler G, Mondillo K, Drevets WC, Blair JR. Impairments of probabilistic response reversal and passive avoidance following catecholamine depletion. Neuropsychopharmacology. 2009;34:2691–8.CrossRefGoogle Scholar
  24. Henriques JB, Davidson RJ. Decreased responsiveness to reward in depression. Cognit Emot. 2000;14:711–24.CrossRefGoogle Scholar
  25. Hess JL, Kawaguchi DM, Wagner KE, Faraone SV, Glatt SJ. The influence of genes on “positive valence systems” constructs: a systematic review. Am J Med Genet B Neuropsychiatr Genet. 2016;171B(1):92–110.CrossRefGoogle Scholar
  26. Hsu DT, Sanford BJ, Meyers KK, Love TM, Hazlett KE, Walker SJ, Mickey BJ, Koeppe RA, Langenecker SA, Zubieta JK. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder. Mol Psychiatry. 2015;20(2):193–200.CrossRefGoogle Scholar
  27. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C, Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167(7):748–51.CrossRefGoogle Scholar
  28. Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 1992;12:483–8.CrossRefGoogle Scholar
  29. Kennedy SH, Giacobbe P. Treatment resistant depression—advances in somatic therapies. Ann Clin Psychiatry. 2007;19:279–87.CrossRefGoogle Scholar
  30. Kennedy SH, Rizvi SJ. Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness. CNS Drugs. 2010;24(6):479–99.CrossRefGoogle Scholar
  31. Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, McInerney SJ, McIntosh D, Milev RV, Muller DJ, Parikh SV, Pearson NL, Ravindran AV, Uher R, CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry. 2016;61:540–60.CrossRefGoogle Scholar
  32. Kirby N, Petry NM, Bickel WK. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen. 1999;128:78–87.CrossRefGoogle Scholar
  33. Knutson B, Bhanji J, Cooney R, Atlas L, Gotlib I. Neural responses to monetary incentives in major depression. Biol Psychiatry. 2008;63:686–92.CrossRefGoogle Scholar
  34. Kring AM, Barch DM. The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs. Eur Neuropsychopharmacol. 2014;24:725–36.CrossRefGoogle Scholar
  35. Kringelbach ML, Stein A, Van Hartevelt TJ. The functional human neuroanatomy of food pleasure cycles. Physiol Behav. 2012;106:307–16.CrossRefGoogle Scholar
  36. Kugaya A, Sanacora G, Verhoeff NP, Fujita M, Mason GF, Seneca NM, Bozkurt A, Khan SA, Anand A, Degen K, Charney DS, Zoghbi SS, Baldwin RM, Seibyl JP, Innis RB. Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT. Biol Psychiatry. 2003;54:792–9.CrossRefGoogle Scholar
  37. Kumar P, Waiter G, Ahearn T, Milders M, Reid I, Steele JD. Abnormal temporal difference reward-learning signals in major depression. Brain. 2008;131:2084–93.CrossRefGoogle Scholar
  38. Kumar P, Berghorst LH, Nickerson LD, Dutra SJ, Goer FK, Greve DN, Pizzagalli DA. Differential effects of acute stress on anticipatory and consummatory phases of reward processing. Neuroscience. 2014;266:1–12.CrossRefGoogle Scholar
  39. Lam RW, Wang J, Enns MW, Kolivakis T, Michalak EE, Sareen J, Song W, Kennedy SH, MacQueen GM, Milev RV, Parikh SV, Ravindran AV, CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care. Can J Psychiatry. 2016;61:510–23.CrossRefGoogle Scholar
  40. Leventhal AM, Chasson GS, Tapia E, Miller EK, Pettit JW. Measuring hedonic capacity in depression: a psychometric analysis of three anhedonia scales. J Clin Psychol. 2006;62:1545–58.CrossRefGoogle Scholar
  41. Lipsman N, Sankar T, Downar J, Kennedy SH, Lozano AM, Giacobbe P. Neuromodulation for treatment-refractory major depressive disorder. CMAJ. 2014;186(1):33–9.CrossRefGoogle Scholar
  42. Malhi GS, Berk M. Does dopamine dysfunction drive depression? Acta Psychiatr Scand. 2007;115(Suppl 433):116–24.CrossRefGoogle Scholar
  43. Malhi GS, Parker GB, Crawford J, Wilhelm K, Mitchell PB. Treatment-resistant depression: resistant to definition? Acta Psychiatr Scand. 2005;112(4):302–9.CrossRefGoogle Scholar
  44. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651–60.CrossRefGoogle Scholar
  45. McCabe C, Cowen PJ, Harmer CJ. Neural representation of reward in recovered depressed patients. Psychopharmacology. 2009;205:667–77.CrossRefGoogle Scholar
  46. McCabe C, Mishor Z, Cowen PJ, Harmer CJ. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry. 2010;67(5):439–45.CrossRefGoogle Scholar
  47. McMakin DL, Olino TM, Porta G, Dietz DJ, Emslie G, Clarke G, Wagner KD, Asarnow JR, Ryan ND, Birmaher B, Shamseddeen W, Mayes T, Kennard B, Spirito A, Keller M, Lynch FL, Dickerson JF, Brent DA. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor-treatment resistant depression. J Am Acad Child Adolesc Psychiatry. 2012;51(4):404–11.CrossRefGoogle Scholar
  48. Murphy FC, Michael A, Robbins TW, Sahakian BJ. Neuropsychological impairments in patients with major depressive disorder: the effects of feedback on task performance. Psychol Med. 2003;33:455–67.CrossRefGoogle Scholar
  49. Pechtel P, Dutra S, Goetz E, Pizzagalli D. Blunted reward responsiveness in remitted depression. J Psychiatr Res. 2013;47:1864–9.CrossRefGoogle Scholar
  50. Pessiglione M, Petrovic P, Daunizeau J, Palminteri S, Dolan RJ, Frith CD. Subliminal instrumental conditioning demonstrated in the human brain. Neuron. 2008;59:561–7.CrossRefGoogle Scholar
  51. Pizzagalli DA, Jahn AL, O’Shea JP. Toward an objective characterization of an anhedonic phenotype: a signal-detection approach. Biol Psychiatry. 2005;57:319–27.CrossRefGoogle Scholar
  52. Pizzagalli DA, Losifescu D, Hallett LA, Ratner KG, Fava M. Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J Psychiatr Res. 2008;43:76–87.CrossRefGoogle Scholar
  53. Prevost C, Pessiglione M, Metereau E, Clery-Melin ML, Dreher JC. Separate valuation subsystems for delay and effort decision costs. J Neurosci. 2010;30(42):14080–90.CrossRefGoogle Scholar
  54. Pulcu E, Trotter PD, Thomas EJ, McFarquhar M, Juhasz G, Sahakian BJ, Deakin JF, Zahn R, Anderson IM, Elliott R. Temporal discounting in major depressive disorder. Psychol Med. 2014;44:1825.CrossRefGoogle Scholar
  55. Rawal A, Collishaw S, Thapar A, Rice F. ‘The risks of playing it safe’: a prospective longitudinal study of response to reward in the adolescent offspring of depressed parents. Psychol Med. 2013;43:27–38.CrossRefGoogle Scholar
  56. Richards JB, Zhang L, Mitchell SH, de Wit H. Delay or probability discounting in a model of impulsive behavior: effect of alcohol. J Exp Anal Behav. 1999;71:121–43.CrossRefGoogle Scholar
  57. Rizvi SJ, Geraci J, Ravindran A, Kennedy SH. Predictors of response to adjunctive osmotic-release methylphenidate or placebo in patients with major depressive disorder: effects of apathy/anhedonia and fatigue. J Clin Psychopharmacol. 2014a;34(6):755–9.CrossRefGoogle Scholar
  58. Rizvi SJ, Grima E, Tan M, Rotzinger S, Lin P, McIntyre RS, Kennedy SH. Treatment-resistant depression in primary care across Canada. Can J Psychiatr. 2014b;59(7):349–57.CrossRefGoogle Scholar
  59. Rizvi SJ, Quilty LC, Sproule BA, Cyriac A, Michael Bagby R, Kennedy SH. Development and validation of the Dimensional Anhedonia Rating Scale (DARS) in a community sample and individuals with major depression. Psychiatry Res. 2015;229(1–2):109–19.CrossRefGoogle Scholar
  60. Rizvi SJ, Pizzagalli DA, Sproule BA, Kennedy SH. Assessing anhedonia in depression: potentials and pitfalls. Neurosci Biobehav Rev. 2016;65:21–35.CrossRefGoogle Scholar
  61. Salamone JD, Correa M, Mingote S, Weber SM. Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. J Pharmacol Exp Ther. 2003;305:1–8.CrossRefGoogle Scholar
  62. Salamone JD, Farrar AM, Font L, Patel V, Schlar DE, Nunes EJ, Collins LE, Sagar TN. Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism. Behav Brain Res. 2009;201:216–22.CrossRefGoogle Scholar
  63. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 1999;56:1043–7.CrossRefGoogle Scholar
  64. Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, Joe AY, Kreft M, Lenartz D, Sturm V. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 2008;33(2):368–77.CrossRefGoogle Scholar
  65. Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol. 1998;80:1–27.CrossRefGoogle Scholar
  66. Schultz W. Updating dopamine reward signals. Curr Opin Neurobiol. 2013;23:229–38.CrossRefGoogle Scholar
  67. Seo H, Lee D. Temporal filtering of reward signals in the dorsal anterior cingulate cortex during a mixed-strategy game. J Neurosci. 2007;27:8366–77.CrossRefGoogle Scholar
  68. Sharma A, Wolf DH, Ciric R, Kable JW, Moore TM, Vandekar SN, Katchmar N, Daldal A, Ruparel K, Davatzikos C, Elliot MA, Calkins ME, Shinohara RT, Bassett DS, Satterthwaite TD. Common dimensional reward deficits across mood and psychotic disorders: a Connectome-Wide Association Study. Am J Psychiatr. 2017;174:657–66.CrossRefGoogle Scholar
  69. Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995;167:99–103.CrossRefGoogle Scholar
  70. Souery D, Amsterdam J, de Montigny C, Lecrubier Y, Montgomery S, Lipp O, Racagni G, Zohar J, Mendlewicz J. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol. 1999;9:83–91.CrossRefGoogle Scholar
  71. Sternat T, Katzman MA. Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse. Neuropsychiatr Dis Treat. 2016;12:2149–64.CrossRefGoogle Scholar
  72. Taylor Tavares JV, Clark L, Furey ML, Williams GB, Sahakian BJ, Drevets WC. Neural basis of abnormal response to negative feedback in unmedicated mood disorders. Neuroimage. 2008;42:1118–26.CrossRefGoogle Scholar
  73. Thomson KR. Measuring anhedonia: impaired ability to pursue, experience, and learn about reward. Front Psychol. 2015;6:1409.CrossRefGoogle Scholar
  74. Treadway MT. The neurobiology of motivational deficits in depression—an update on candidate pathomechanisms. Curr Top Behav Neurosci. 2015;27:337–55.CrossRefGoogle Scholar
  75. Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev. 2011;35(3):537–55.CrossRefGoogle Scholar
  76. Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH. Worth the ‘EEfRT’? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One. 2009;4:e6598.CrossRefGoogle Scholar
  77. Treadway MT, Bossaller N, Shelton RC, Zald DH. Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol. 2012;121(3):553–8.CrossRefGoogle Scholar
  78. Tremblay LK, Naranjo CA, Graham SJ, Herrmann N, Mayberg HS, Hevenor S, Busto UE. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry. 2005;62:1228–36.CrossRefGoogle Scholar
  79. Tso IF, Grove TB, Taylor SF. Differential hedonic experience and behavioral activation in schizophrenia and bipolar disorder. Psychiatry Res. 2014;219:470–6.CrossRefGoogle Scholar
  80. Uher R, Farmer A, Maier W, Rietschel M, Hauser J, Marusic A, Mors O, Elkin A, Williamson RJ, Schmael C, Henigsberg N, Perez J, Mendlewicz J, Janzing JG, Zobel A, Skibinska M, Kozel D, Stamp AS, Bajs M, Placentino A, Barreto M, McGuffin P, Aitchison KJ. Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med. 2008;38:289–300.CrossRefGoogle Scholar
  81. Uher R, Perlis RH, Henigsberg N, Zobel A, Rietschel M, Mors O, Hauser J, Dernovsek Z, Souery D, Bajs M, Maier W, Aitchison KJ, Farmer A, McGuffin P. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med. 2012;42(5):967–80.CrossRefGoogle Scholar
  82. Vengeliene V, Bespalov A, Robmanith M, Horschitz S, Berger S, Relo AL, Noori HR, Schneider P, Enkel T, Bartsch D, Schneider M, Behl B, Hansson AC, Schloss P, Spanagel R. Toward trans-diagnostic mechanisms in psychiatry: neurobehavioral profile of rats with a loss-of-function point mutation in the dopamine transporter gene. Dis Model Mech. 2017;10(4):451–61.CrossRefGoogle Scholar
  83. Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. The STAR*D project results: a comprehensive review of findings. Curr Psychiatry Rep. 2007;9(6):449–59.CrossRefGoogle Scholar
  84. Wassum KM, Ostlund SB, Maidment NT, Balleine BW. Distinct opioid circuits determine the palatability and the desirability of rewarding events. Proc Natl Acad Sci U S A. 2009;106:12512–7.CrossRefGoogle Scholar
  85. Whitton AE, Treadway MT, Pizzagalli DA. Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr Opin Psychiatry. 2015;28(1):7–12.CrossRefGoogle Scholar
  86. Wong LS, Eshel G, Dreher J, Ong J, Jackson DM. Role of dopamine and GABA in the control of motor activity elicited from the rat nucleus accumbens. Pharmacol Biochem Behav. 1991;38:829–35.CrossRefGoogle Scholar
  87. World Health Organization. Depression fact sheet. 2017.
  88. Zhang B, Lin P, Shi H, Ongur D, Auerbach RP, Wang X, Yao S, Wang X. Mapping anhedonia-specific dysfunction in a transdiagnostic approach: an ALE meta-analysis. Brain Imaging Behav. 2016;10:920–39.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Troy K. Chow
    • 1
    • 2
  • Sidney Kennedy
    • 1
    • 2
    • 3
  • Sakina J. Rizvi
    • 1
    • 2
    • 3
  1. 1.Arthur Sommer Rotenberg Suicide and Depression Studies UnitSt. Michael’s HospitalTorontoCanada
  2. 2.Institute of Medical SciencesUniversity of TorontoTorontoCanada
  3. 3.Department of PsychiatryUniversity of TorontoTorontoCanada

Personalised recommendations